Overview

Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show that in patients suffering from perennial allergic rhinitis levocetirizine 5 mg OD relieves nasal obstruction. Furthermore the study is to investigate how relevant for these patients their nasal obstruction and the effect of levocetirizine on their nasal obstruction are.
Phase:
Phase 4
Details
Lead Sponsor:
Institut für Atemwegsforschung GmbH
Collaborator:
UCB Pharma
Treatments:
Cetirizine
Levocetirizine